Pediatrix Medical Group Statistics
Total Valuation
MD has a market cap or net worth of $2.08 billion. The enterprise value is $2.26 billion.
| Market Cap | 2.08B |
| Enterprise Value | 2.26B |
Important Dates
The last earnings date was Monday, November 3, 2025, before market open.
| Earnings Date | Nov 3, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MD has 84.18 million shares outstanding. The number of shares has increased by 2.48% in one year.
| Current Share Class | 84.18M |
| Shares Outstanding | 84.18M |
| Shares Change (YoY) | +2.48% |
| Shares Change (QoQ) | +0.10% |
| Owned by Insiders (%) | 1.29% |
| Owned by Institutions (%) | 96.91% |
| Float | 83.05M |
Valuation Ratios
The trailing PE ratio is 12.92 and the forward PE ratio is 11.43.
| PE Ratio | 12.92 |
| Forward PE | 11.43 |
| PS Ratio | 1.05 |
| Forward PS | 1.04 |
| PB Ratio | 2.25 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 7.62 |
| P/OCF Ratio | 7.19 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.79, with an EV/FCF ratio of 8.28.
| EV / Earnings | 13.96 |
| EV / Sales | 1.18 |
| EV / EBITDA | 8.79 |
| EV / EBIT | 9.65 |
| EV / FCF | 8.28 |
Financial Position
The company has a current ratio of 1.83, with a Debt / Equity ratio of 0.72.
| Current Ratio | 1.83 |
| Quick Ratio | 1.78 |
| Debt / Equity | 0.72 |
| Debt / EBITDA | 2.24 |
| Debt / FCF | 2.35 |
| Interest Coverage | 6.35 |
Financial Efficiency
Return on equity (ROE) is 19.98% and return on invested capital (ROIC) is 9.94%.
| Return on Equity (ROE) | 19.98% |
| Return on Assets (ROA) | 6.86% |
| Return on Invested Capital (ROIC) | 9.94% |
| Return on Capital Employed (ROCE) | 12.98% |
| Revenue Per Employee | $466,612 |
| Profits Per Employee | $39,365 |
| Employee Count | 4,120 |
| Asset Turnover | 0.90 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MD has paid $41.98 million in taxes.
| Income Tax | 41.98M |
| Effective Tax Rate | 20.56% |
Stock Price Statistics
The stock price has increased by +64.64% in the last 52 weeks. The beta is 0.81, so MD's price volatility has been lower than the market average.
| Beta (5Y) | 0.81 |
| 52-Week Price Change | +64.64% |
| 50-Day Moving Average | 18.79 |
| 200-Day Moving Average | 15.40 |
| Relative Strength Index (RSI) | 83.89 |
| Average Volume (20 Days) | 1,245,010 |
Short Selling Information
The latest short interest is 3.02 million, so 3.59% of the outstanding shares have been sold short.
| Short Interest | 3.02M |
| Short Previous Month | 2.55M |
| Short % of Shares Out | 3.59% |
| Short % of Float | 3.63% |
| Short Ratio (days to cover) | 4.07 |
Income Statement
In the last 12 months, MD had revenue of $1.92 billion and earned $162.19 million in profits. Earnings per share was $1.91.
| Revenue | 1.92B |
| Gross Profit | 496.25M |
| Operating Income | 234.51M |
| Pretax Income | 204.17M |
| Net Income | 162.19M |
| EBITDA | 257.58M |
| EBIT | 234.51M |
| Earnings Per Share (EPS) | $1.91 |
Balance Sheet
The company has $463.10 million in cash and $642.27 million in debt, giving a net cash position of -$179.17 million or -$2.13 per share.
| Cash & Cash Equivalents | 463.10M |
| Total Debt | 642.27M |
| Net Cash | -179.17M |
| Net Cash Per Share | -$2.13 |
| Equity (Book Value) | 890.67M |
| Book Value Per Share | 10.59 |
| Working Capital | 324.65M |
Cash Flow
In the last 12 months, operating cash flow was $290.00 million and capital expenditures -$16.61 million, giving a free cash flow of $273.39 million.
| Operating Cash Flow | 290.00M |
| Capital Expenditures | -16.61M |
| Free Cash Flow | 273.39M |
| FCF Per Share | $3.25 |
Margins
Gross margin is 25.81%, with operating and profit margins of 12.20% and 8.44%.
| Gross Margin | 25.81% |
| Operating Margin | 12.20% |
| Pretax Margin | 10.62% |
| Profit Margin | 8.44% |
| EBITDA Margin | 13.40% |
| EBIT Margin | 12.20% |
| FCF Margin | 14.22% |
Dividends & Yields
MD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.48% |
| Shareholder Yield | -2.48% |
| Earnings Yield | 7.78% |
| FCF Yield | 13.12% |
Analyst Forecast
The average price target for MD is $21.00, which is -14.84% lower than the current price. The consensus rating is "Hold".
| Price Target | $21.00 |
| Price Target Difference | -14.84% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 2.78% |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 20, 2013. It was a forward split with a ratio of 2:1.
| Last Split Date | Dec 20, 2013 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
MD has an Altman Z-Score of 1.88 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.88 |
| Piotroski F-Score | 7 |